With the widespread clinical application of immunotherapy drugs represented by PD-1/PD-L1 inhibitors, tumor treatment has entered a new era, and more and more tumor patients benefit from immunotherapy. In order to promote the overall development of oncology medicine and further improve the level of diagnosis and treatment of oncology diseases, Chengdu High-tech Medical Association successfully held three oncology treatment series academic conferences in May-July-Immunity Experts said. The conference invited well-known experts in related fields to give lectures on tumor immunotherapy and other related content, and to share the latest research progress.

The first immunization expert said that it was successfully held in Chengdu on May 30. Professor Mei Hou gave an opening speech and a summary. Professor Zhou Lin, Professor Zhou Xiaojuan, Professor Zhang Shuang, Professor Zhang Ying and Professor Yu Yang gave wonderful explanations and analyses on relevant clinical cases of immunotherapy.

The second immunization expert said that it was successfully held in Zigong City on June 26. The presidium composed of Professor Miao Jidong from the Fourth People’s Hospital of Zigong City, Professor Gong Youling from West China Hospital of Sichuan University and Professor Ao Rui from Sichuan Provincial People’s Hospital delivered opening speeches and conclusions. Professor Zhu Xueqiang, Professor Liu Yongmei, Professor Huang Hui, Miao Jidong Professor and Professor Ge Jun focused on clinical practice cases of esophageal cancer, colon cancer and head and neck cancer, and launched a wonderful analysis. On July 17, the third immunization expert said the meeting ended successfully in Leshan City.

This series of academic conferences on tumor treatment, with the theme of "multiple perspectives, clinical speculation", carried out three wonderful immunotherapy related seminars, in order to promote the overall development of oncology medicine communication in the province, which is conducive to further improvement The level of diagnosis and treatment of tumor diseases.